arrow
M

Margrét Sigurðardóttir

University of Iceland
H指数:14
被引数:1,046

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study

弥漫性多发性骨髓瘤患者感染风险增加:来自筛查的iStopMM研究的结果

Leukemia
IF13.4
2025-09-120
OAAI
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

下一代流式细胞术分析克隆性骨髓浆细胞,识别出一类惰性MGUS亚群

2025-08-210
OAAI
Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients
2024-12-110
OAAI
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
2024-11-190
OAAI
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
2024-06-180
PRE
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceA Cohort Study Nested in a Clinical Trial
2024-04-011
PRE
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
2024-01-110
OAAI
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
2023-12-013
OAAI
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
2023-07-1318
OAAI
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening(feb, 10.1038/s41591-022-02183-6, 2023)
2023-03-200
OA
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (vol 11, 94, 2021)
2023-03-201
OAAI
Prevalence of smoldering multiple myeloma based on nationwide screening

基于全国筛查的阴燃性多发性骨髓瘤患病率

2023-02-0633
PRE
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
2022-09-1447
OAAI
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
2021-12-015
OAAI
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

冰岛筛查,治疗或预防多发性骨髓瘤 (iStopMM): 一项基于人群的未确定意义的单克隆丙种球蛋白病筛查研究和随访策略的随机对照试验

2021-05-1769
OAAI